Compare Firy Inc. (FIRY) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Firy Inc. vs ResMed Inc. — how do they compare? Firy Inc. trades at $12.03 (market cap $199.80M), while ResMed Inc. trades at $230.12 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 159.6× Firy Inc.'s market cap, and ResMed Inc. pays a 1.16% dividend while Firy Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and ResMed Inc. for 51 Days on average.
| FIRY | RMD | |
|---|---|---|
Market Cap | $199.80M | $31.89B |
Volume | 92,993 | 618,314 |
Sector | Technology | Health |
52-Week High | $13.10 | $277.88 |
52-Week Low | $2.28 | $182.82 |
Typical Hold Time | 13 Days | 51 Days |
Enterprise Value | $168.40M | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.07, up 1.86% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $31.0 million but a net loss, continuing a trend of negative profitability. Recent developments include a major legal victory with a $719 million judgment and the appointment of Marc Lasry to the board, signaling strategic shifts under its new holding company structure.
The outlook remains challenged by persistent cash burn and negative margins, though the legal win offers potential upside. Risks include high cash outflow and competitive pressures. Analyst sentiment is mixed with a hold-dominated consensus, reflecting uncertainty around the company's path to profitability.
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
